Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis
- Registry ID
- EUCTR2014-004919-36
- Source registry
- EUCTR
- Phase
- PHASE3
- Sponsor
- Schering-Plough Research Institute, a Division of Schering Corporation
- Last update
- 2026-08-16
Conditions
- SEASONAL ALLERGIC RHINITIS (SAR)
Summary
The primary objective of this study was to assess the efficacy in relieving the symptom of nasal
congestion with MFNS 200 mcg given once daily compared to placebo in subjects with symptomatic SAR.
View on source registry